While policy debates continue over the 15-year horizon for the National Health Insurance (NHI) and its planned Single Electronic Health Record (SEHR), a quieter, faster transformation has already ...

The consequences of President Trump's actions on drug pricing continue to play out, with Bristol Myers Squibb insisting it will charge the same in the UK for new schizophrenia drug Cobenfy as in the ...

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Bristol Myers Squibb is partnering up with Evinova’s AI clinical development platform across the Big Pharma company’s global portfolio in an effort to improve efficiency and cut costs. The agreement ...

Cardi B seemingly takes shots at Stefon Diggs in scathing concert rant post-breakup originally appeared on The Sporting News.

From today, thousands more Australians living with advanced and rare cancers will have access to affordable immunotherapy treatment options through ...

CEO Christopher Boerner opened by highlighting, “2025 was a year of focused execution across the business. We believe our results further demonstrate the ongoing strength in our growth portfolio as we ...

Robert Burakoff, MD, MPH, is a board-certified gastroenterologist who serves as vice chair of Ambulatory Services at Lower Manhattan Hospital and professor of medicine at the Weill Cornell Medical ...